Free Trial

Tandem Diabetes Care (TNDM) Competitors

Tandem Diabetes Care logo
$17.71 +0.68 (+3.99%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$17.71 0.00 (0.00%)
As of 04/15/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNDM vs. INSP, BLCO, SLNO, IRTC, PRCT, NVST, TMDX, LIVN, ENOV, and NVCR

Should you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.

Tandem Diabetes Care vs.

Inspire Medical Systems (NYSE:INSP) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, community ranking, profitability, institutional ownership, risk, analyst recommendations and valuation.

Inspire Medical Systems has a net margin of 6.67% compared to Tandem Diabetes Care's net margin of -14.84%. Inspire Medical Systems' return on equity of 8.19% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems6.67% 8.19% 7.09%
Tandem Diabetes Care -14.84%-44.19%-11.99%

Tandem Diabetes Care received 393 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. However, 61.78% of users gave Inspire Medical Systems an outperform vote while only 60.89% of users gave Tandem Diabetes Care an outperform vote.

CompanyUnderperformOutperform
Inspire Medical SystemsOutperform Votes
194
61.78%
Underperform Votes
120
38.22%
Tandem Diabetes CareOutperform Votes
587
60.89%
Underperform Votes
377
39.11%

In the previous week, Tandem Diabetes Care had 7 more articles in the media than Inspire Medical Systems. MarketBeat recorded 22 mentions for Tandem Diabetes Care and 15 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.66 beat Tandem Diabetes Care's score of 1.28 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
13 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Tandem Diabetes Care
13 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.2% of Tandem Diabetes Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inspire Medical Systems has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$802.80M5.43$53.51M$1.7384.73
Tandem Diabetes Care$940.20M1.25-$222.61M-$1.46-12.13

Inspire Medical Systems has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500.

Inspire Medical Systems presently has a consensus target price of $222.20, suggesting a potential upside of 51.58%. Tandem Diabetes Care has a consensus target price of $43.88, suggesting a potential upside of 147.78%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Tandem Diabetes Care
0 Sell rating(s)
8 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.58

Summary

Inspire Medical Systems beats Tandem Diabetes Care on 12 of the 18 factors compared between the two stocks.

Remove Ads
Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNDM vs. The Competition

MetricTandem Diabetes CareSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.18B$4.09B$5.33B$7.57B
Dividend YieldN/A39.50%5.11%4.33%
P/E Ratio-9.1828.0221.8317.81
Price / Sales1.2547.80379.4694.58
Price / CashN/A51.0838.1534.64
Price / Book3.685.826.454.00
Net Income-$222.61M$67.09M$3.20B$247.23M
7 Day Performance8.19%5.59%6.60%7.26%
1 Month Performance-7.62%-3.25%-8.50%-6.26%
1 Year Performance-44.41%14.72%10.33%-0.18%

Tandem Diabetes Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNDM
Tandem Diabetes Care
4.2123 of 5 stars
$17.71
+4.0%
$43.88
+147.8%
-44.4%$1.13B$940.20M-9.182,600News Coverage
Positive News
Gap Down
INSP
Inspire Medical Systems
4.6381 of 5 stars
$149.72
+5.5%
$226.70
+51.4%
-34.3%$4.46B$802.80M86.541,246Analyst Forecast
News Coverage
Positive News
Gap Up
BLCO
Bausch + Lomb
3.8719 of 5 stars
$11.86
-2.1%
$18.82
+58.7%
-16.5%$4.18B$4.79B-13.0312,500Gap Down
SLNO
Soleno Therapeutics
4.7804 of 5 stars
$69.16
+2.5%
$99.63
+44.0%
+82.4%$3.17BN/A-20.8330Analyst Forecast
Gap Down
High Trading Volume
IRTC
iRhythm Technologies
0.9177 of 5 stars
$100.29
0.0%
$119.73
+19.4%
-8.0%$3.15B$591.84M-27.551,790Positive News
PRCT
PROCEPT BioRobotics
2.3993 of 5 stars
$50.84
-0.8%
$94.29
+85.5%
+4.6%$2.79B$224.50M-26.07430Positive News
Gap Down
NVST
Envista
4.3811 of 5 stars
$15.27
-1.4%
$20.18
+32.2%
-21.0%$2.63B$2.51B-2.3512,700Analyst Forecast
Analyst Revision
News Coverage
Positive News
Gap Down
TMDX
TransMedics Group
2.7688 of 5 stars
$68.99
+1.9%
$122.70
+77.9%
-5.1%$2.32B$441.54M73.39210
LIVN
LivaNova
3.555 of 5 stars
$35.43
-1.5%
$61.17
+72.7%
-34.8%$1.93B$1.25B84.352,900News Coverage
Positive News
Gap Down
ENOV
Enovis
2.2051 of 5 stars
$32.41
-0.4%
$58.50
+80.5%
-44.7%$1.85B$2.11B-14.806,800Gap Down
NVCR
NovoCure
3.3286 of 5 stars
$16.62
+0.8%
$35.80
+115.4%
+29.4%$1.83B$605.22M-11.871,320
Remove Ads

Related Companies and Tools


This page (NASDAQ:TNDM) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners